Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
SARS-CoV-2 3C 样蛋白酶抑制剂辛诺瑞韦的结构开发和临床前评估
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-023-42102-y
Xiangrui Jiang #, Haixia Su #, Weijuan Shang #, Feng Zhou #, Yan Zhang #, Wenfeng Zhao #, Qiumeng Zhang, Hang Xie, Lei Jiang, Tianqing Nie, Feipu Yang, Muya Xiong, Xiaoxing Huang, Minjun Li, Ping Chen, Shaoping Peng, Gengfu Xiao, Hualiang Jiang, Renhong Tang, Leike Zhang, Jingshan Shen, Yechun Xu
